Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial

Authors: Klaus F. Rabe, Bartolomé R. Celli, Michael E. Wechsler, Raolat M. Abdulai, Xiaodong Luo, Maarten M. Boomsma, Heribert Staudinger, Julie Horowitz, Aris Baras, Manuel A. R. Ferreira, Marcella Ruddy, Michael C. Nivens, Nikhil Amin, David M. Weinreich, George D. Yancopoulos, Hélène Goulaouic - The Lancet 2021 cited by 206